Mandating processes that are not evidence based generates distress among patients and clinicians, so physician advocacy in national, state, and local policymaking is key.
AMA J Ethics. 2020;22(8):E668-674. doi:
10.1001/amajethics.2020.668.
A 3-step analgesic ladder was introduced in 1986 and needs change. Surgical interventions could reduce opioid use and motivate expansion of current pain management approaches.
AMA J Ethics. 2020;22(8):E695-701. doi:
10.1001/amajethics.2020.695.
Pain is the most common reason patients seek health care. The AMA Pain Care Task Force suggests how clinicians can offer good pain care and become savvy about situating themselves in the health care system to do so.
AMA J Ethics. 2020;22(8):E709-717. doi:
10.1001/amajethics.2020.709.
Driven by toxic, unpredictable, unregulated supply, drug overdose deaths are rampant. Policies that support the war on drugs have to change to be helpful.
AMA J Ethics. 2020;22(8):E723-728. doi:
10.1001/amajethics.2020.723.
Jonathan Alhalel, Nicolás Francone, Sharon Post, Catherine A. O’Brian, PhD, and Melissa A. Simon, MD, MPH
Underrepresentation of individuals with limited English proficiency who speak Spanish is ongoing in phase 3 biomedical clinical trials and exacerbates health inequity.
AMA J Ethics. 2022;24(4):E319-325. doi:
10.1001/amajethics.2022.319.